SEC Comment Letter 0000000000-22-012358 to Medinotec Inc. (MDNC) (CIK 0001931055) (MDNC)
Medinotec Inc. (MDNC) (CIK 0001931055)
Date: Nov. 14, 2022 · CIK: 0001931055 · Accession: 0000000000-22-012358
AI Filing Summary & Sentiment
File numbers found in text: 333-265368
Show Raw Text
United States securities and exchange commission logo
November 14, 2022
Gregory Vizirgianakis
Chief Executive Officer
Medinotec Inc.
Northlands Deco Park
10 New Market Street
Stand 299 Avant Garde Avenue
North Riding 2169
Re:Medinotec Inc.
Amendment No. 4 to Registration Statement on Form S-1
Filed November 2, 2022
File No. 333-265368
Dear Gregory Vizirgianakis:
We have reviewed your amended registration statement and have the following
comments. In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments. Unless we note
otherwise, our references to prior comments are to comments in our October 13, 2022 letter.
Amendment No. 4 to Registration Statement on Form S-1
Management's Discussion and Analysis of Financial Condition and Results of Operations, page
73
1.We note your revisions to this section, particularly the change to tabular form and your
comparisons of financial information for different periods and entities. Please revise
to "[p]rovide the analysis in a format that facilitates easy understanding and that
supplements, and does not duplicate, disclosure already provided in the filing," as
provided in Instruction 3 to Item 303(b) of Regulation S-K.
FirstName LastNameGregory Vizirgianakis
Comapany NameMedinotec Inc.
November 14, 2022 Page 2
FirstName LastName
Gregory Vizirgianakis
Medinotec Inc.
November 14, 2022
Page 2
Medinotec Incorporated Group
Unaudited Notes to Financial Statements
Note 12 - Business Acquisitions
Acquisition of DISA Medinotec Proprietary Limited, page F-44
2.We have considered your response to our prior comment 4, including your management
discussion of results on page 75 and we re-issue our comment. It does not appear that your
financial statements for the prior comparative period ended August 31, 2021 reflects the
combined results of all entities starting at the beginning of the period, which is March 1,
2021, as required by ASC 805-50-45-5. During the interim periods presented, the control
of entities had not changed and thus the retroactive presentation of prior periods as if such
structure existed at that time is required. As such, the interim financial statements should
reflect DISA, the operating company, starting on March 1, 2021 through August 31, 2021,
combined with the results of the parent starting on April 26, 2021, the date of formation.
Please revise your interim financial statements accordingly and clearly disclose that the
financial information of previously separate entities are combined.
In addition, please revise your Management Discussion on page 75 to address these
combined results. As such, pro forma presentation would not be required.
You may contact Gary Newberry at (202) 551-3761 or Sasha Parikh at (202) 551-3627 if
you have questions regarding comments on the financial statements and related matters. Please
contact Abby Adams at (202) 551-6902 or Alan Campbell at (202) 551-4224 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Scott Doney, Esq.